Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2
about
Structures of BIR domains from human NAIP and cIAP2Recognition of Smac-mimetic compounds by the BIR domain of cIAP1Structural Insight into Inhibitor of Apoptosis Proteins Recognition by a Potent Divalent Smac-MimeticEctopic expression of new alternative splice variant of Smac/DIABLO increases mammospheres formationHigh-throughput screening for modulators of protein-protein interactions: use of photonic crystal biosensors and complementary technologies.Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and BortezomibBV6, an IAP antagonist, activates apoptosis and enhances radiosensitization of non-small cell lung carcinoma in vitroPotential therapeutic benefits of strategies directed to mitochondria.HAX1 regulates E3 ubiquitin ligase activity of cIAPs by promoting their dimerization2P2I HUNTER: a tool for filtering orthosteric protein-protein interaction modulators via a dedicated support vector machine.Small molecules, big targets: drug discovery faces the protein-protein interaction challenge.Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling.Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2.Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonist.Loss of cellular inhibitor of apoptosis protein 2 reduces atherosclerosis in atherogenic apoE-/- C57BL/6 mice on high-fat diet.A NMR and computational study of Smac mimics targeting both the BIR2 and BIR3 domains in XIAP protein.
P2860
Q24656690-38A04E92-063C-4D75-B968-C39E9C576F44Q27665119-600E8E93-AD83-4B21-8BD6-A0D8553CC876Q27675179-3683A0A8-29B2-401F-90FD-EAA5551B2CD1Q28250105-E2E963D5-CB0A-49D6-B787-63CDACD6680AQ33765623-DD1D57EF-F845-4210-8B1D-0C2F935B3F94Q33906039-81DD2C85-B597-41A6-9171-F0EFD1E3EED0Q33961325-F7384ADC-6F96-42E8-9ABC-5401DABABE90Q34117168-24E54B27-132E-4220-9CBC-6213CF332E93Q34654418-B1ED28CA-16A4-4058-951C-8D5363B9C4E4Q35033136-653130D9-85DA-4B0E-ABE4-701471EBA9B2Q35981250-982BE5B2-9F8C-43D1-94C0-F356BCA5C327Q37621033-8A618930-C5CC-48A6-B9B2-6DB842B2CF93Q38391583-33280FFA-9316-4A29-BB40-4B4AFD3B623BQ39664088-259EA9F6-E325-4B25-8AD4-18D47D76549EQ42875604-30F8A843-F2F7-4E93-9488-CBBB995D7588Q46806247-286F8C1F-1C39-409B-BB61-420AA7FBBD0A
P2860
Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2
@ast
Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2
@en
Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2
@nl
type
label
Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2
@ast
Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2
@en
Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2
@nl
prefLabel
Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2
@ast
Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2
@en
Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2
@nl
P2093
P50
P1476
Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2
@en
P2093
Carlo Scolastico
Domenico Delia
Graziella Sorrentino
P356
10.1016/J.BBRC.2008.10.139
P407
P50
P577
2009-01-09T00:00:00Z